Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Toronto Dominion Bank Sells 22878 Shares of Biogen Inc. NASDAQ:BIIB

December 16, 2024
In a surprising move, Toronto Dominion Bank has sold 22,878 shares of Biogen Inc., a leading biotechnology company listed on NASDAQ with the ticker symbol BIIB. This sale has raised eyebrows among investors, as Biogen has been making significant strides in the healthcare industry, especially with its recent drug developments and clinical trials. While the reason behind this sell-off remains unclear, it is essential to note that the stock has been performing well and has shown resilience even during difficult market conditions. Biogen's innovative approach to developing treatments for severe diseases has garnered attention from both investors and industry experts. For a more accurate prediction of future movements in Biogen Inc. stocks, it is recommended to consult professionals from Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for BIIB

Related data

BIIBJune 11, 2025Biogen Inc. Presents Exciting Advances at Goldman Sachs Conference  ~1 min.

Biogen Inc. recently presented at the Goldman Sachs 46th Annual Global Healthcare Conference, showcasing their latest innovations in the healthcare sector....

BIIBApril 7, 2025Biogen Inc. Stock Hits Price Target Forecast on QuantWave, Generating 13.05% Profit  ~1 min.

In a recent development on QuantWave, the stock of Biogen Inc. has successfully reached the price target forecast, resulting in a profitable outcome for users....

BIIBApril 6, 2025Biogen Inc. Continues to Struggle with Declining Earnings and Investor Returns  ~2 min.

Biogen Inc., a leading biotechnology company, has reported a significant decrease in company earnings, losing a staggering US$697 million....

BIIBApril 4, 2025Biogen Inc. Stock Hits QuantWave Forecast Target with 11.12% Profit  ~2 min.

Biogen Inc. stock recently achieved the price target forecast set by QuantWave, signaling a successful prediction for investors....

BIIBApril 4, 2025Biogen Inc. Hits Price Target Forecast on QuantWave with 12.72% Profit  ~1 min.

Biogen Inc. has successfully reached the price target forecast set by QuantWave, resulting in a profit of 12.72%. The forecast signal was issued on March 21, 2025, when the stock was priced at 140.9 $....

BIIBApril 4, 2025Biogen Inc. Stock Hits Forecast Price Target with 12.95% Profit, Confirms QuantWave's Accuracy  ~2 min.

Biogen Inc., a leading biotechnology company, recently achieved the price target forecast set by QuantWave, confirming the platform's accuracy and reliability in predicting stock movements....

BIIBApril 4, 2025Biogen Inc. Stock Hits Profit Target with 14.28% Gain in Short Position Forecast  ~2 min.

Biogen Inc. stock successfully reached the price target forecasted by QuantWave on April 4, 2025, resulting in a profit of 14.28% for investors who followed the short position prediction....

BIIBApril 4, 2025Biogen Inc. Hits Forecast Target with 11.8% Profit: A Win for QuantWave Analysis  ~1 min.

Biogen Inc. recently achieved its forecast price target as predicted by QuantWave on March 14, 2025. The stock was expected to move in a short direction, with a price of $139.44 at the time of the signal....

BIIBApril 4, 2025Biogen Inc. Hits Short Price Target with 13.79% Profit - QuantWave Forecast Success  ~1 min.

Biogen Inc. (BIIB) recently saw its stock price hit the forecasted short price target of 122.98 $ on April 4, 2025, as predicted by QuantWave on March 4, 2025....

BIIBApril 4, 2025Biogen Inc. Hits Forecast Price Target with Profit of 12.47% - QuantWave Achieves Success in Stock Prediction  ~1 min.

Biogen Inc. managed to reach the price target set by QuantWave with a profit of 12.47% on April 4, 2025....

BIIBJanuary 2, 2025Biogen Inc. BIIB: Potential for Long-Term Value Growth  ~2 min.

Biogen Inc. (NASDAQ:BIIB) is a leading biotechnology company focused on the development and commercialization of therapies for neurological and neurodegenerative diseases....

BIIBMarch 14, 2025State of Michigan Retirement System Increases Stake in Biogen Inc.  ~1 min.

State of Michigan Retirement System has increased its position in Biogen Inc. (NASDAQ:BIIB) by a significant margin....

JNJMarch 14, 2025Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments  ~1 min.

Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....

BIIBDecember 15, 2024Inspire Trust Co. N.A. Grows Stock Holdings in Biogen Inc. NASDAQ:BIIB  ~1 min.

Recently, Inspire Trust Co. N.A. has increased its stock holdings in Biogen Inc. (NASDAQ:BIIB), expressing its confidence in the company's future prospects. Biogen Inc....

BIIBMarch 17, 2025Why Is Biogen BIIB Up 1.1 Since Last Earnings Report?  ~2 min.

Biogen Inc. (NASDAQ:BIIB), a leading biotechnology company, has witnessed a 1.1% increase in stock value since its last earnings report....